Repurposing rosmarinic acid as an anti-colorectal cancer agent through bolstering T cell anti-tumor immunity by enhancing activation of MEK1-mediated TCR signaling.
Saved in:
| Title: | Repurposing rosmarinic acid as an anti-colorectal cancer agent through bolstering T cell anti-tumor immunity by enhancing activation of MEK1-mediated TCR signaling. |
|---|---|
| Authors: | Kang Z; Department of Colorectal Surgery, Changhai Hospital, Naval Medical University, Shanghai, 200433, China., Li X; Department of Colorectal Surgery, Changhai Hospital, Naval Medical University, Shanghai, 200433, China., Ma X; Department of Colorectal Surgery, Changhai Hospital, Naval Medical University, Shanghai, 200433, China., Yan F; Department of Colorectal Surgery, Changhai Hospital, Naval Medical University, Shanghai, 200433, China. feihu_1989@163.com., Wang Z; Department of Colorectal Surgery, Changhai Hospital, Naval Medical University, Shanghai, 200433, China. dr_wangzhen@163.com. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Apr 02; Vol. 75 (4). Date of Electronic Publication: 2026 Apr 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41925912 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Repurposing rosmarinic acid as an anti-colorectal cancer agent through bolstering T cell anti-tumor immunity by enhancing activation of MEK1-mediated TCR signaling. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kang+Z%22">Kang Z</searchLink>; Department of Colorectal Surgery, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Department of Colorectal Surgery, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.<br /><searchLink fieldCode="AU" term="%22Ma+X%22">Ma X</searchLink>; Department of Colorectal Surgery, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.<br /><searchLink fieldCode="AU" term="%22Yan+F%22">Yan F</searchLink>; Department of Colorectal Surgery, Changhai Hospital, Naval Medical University, Shanghai, 200433, China. feihu&#95;1989@163.com.<br /><searchLink fieldCode="AU" term="%22Wang+Z%22">Wang Z</searchLink>; Department of Colorectal Surgery, Changhai Hospital, Naval Medical University, Shanghai, 200433, China. dr&#95;wangzhen@163.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2026 Apr 02; Vol. 75 (4). <i>Date of Electronic Publication: </i>2026 Apr 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41925912 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00262-026-04366-3 Languages: – Code: eng Text: English Titles: – TitleFull: Repurposing rosmarinic acid as an anti-colorectal cancer agent through bolstering T cell anti-tumor immunity by enhancing activation of MEK1-mediated TCR signaling. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kang Z – PersonEntity: Name: NameFull: Li X – PersonEntity: Name: NameFull: Ma X – PersonEntity: Name: NameFull: Yan F – PersonEntity: Name: NameFull: Wang Z IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 04 Text: 2026 Apr 02 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1432-0851 Numbering: – Type: volume Value: 75 – Type: issue Value: 4 Titles: – TitleFull: Cancer immunology, immunotherapy : CII Type: main |
| ResultId | 1 |